Blog
RSS FeedPosted by Michael Wonder on 13 Nov 2021
Public Summary Documents (first time rejections and deferrals) – July 2021 PBAC meeting
12 November 2021 - The Public Summary Documents (first time rejections and deferrals) from the July 2021 PBAC meeting are now ...
Posted by Michael Wonder on 12 Nov 2021
Progress update: post-market review of medicines for smoking cessation
12 November 2021 - In June 2021, the Drug Utilisation Sub-Committee and the Economics Sub-Committee of the PBAC considered the report ...
Posted by Michael Wonder on 10 Nov 2021
Universal health care is a fundamental right — being delusional is not
10 November 2021 - Singapore’s Health Ministry has announced that its citizens who choose not to be vaccinated will be ...
Posted by Michael Wonder on 07 Nov 2021
Start of COVID-19 booster vaccination program
8 November 2021 - Today, the Australian Government’s COVID-19 booster vaccination rollout program officially gets under way, with the initial focus ...
Posted by Michael Wonder on 06 Nov 2021
Pharmaceutical Benefits Scheme continued dispensing arrangements
5 November 2021 - The Australian Government has extended the Continued Dispensing emergency arrangements until 30 June 2022, when they ...
Posted by Michael Wonder on 05 Nov 2021
Drug Utilisation Sub-Committee outcome statement
5 November 2021 - The Outcome Statement from the October 2021 Drug Utilisation SubCommittee meeting is now available. ...
Posted by Michael Wonder on 03 Nov 2021
Department of Health tweaks agenda for this week's PBAC meeting
1 November 2021 - This is the tenth revision to the agenda for this week's PBAC meeting. ...
Posted by Michael Wonder on 01 Nov 2021
Australia to subsidise multiple myeloma drug Darzalex under PBS
31 October 2021 - Blood cancer patients will be among those to benefit with better access to medicine under the Pharmaceutical ...
Posted by Michael Wonder on 31 Oct 2021
Prostate cancer treatment to be put on PBS
31 October 2021 - For the first time in seven years, a prostate cancer therapy will be added to the ...
Posted by Michael Wonder on 31 Oct 2021
Schedule of Pharmaceutical Benefits - 1 November 2021 update
1 November 2021 - The November 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Oct 2021
Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme
1 November 2021 - In the event of a medicine shortage, a provision under section 19A of the Therapeutic Goods ...
Posted by Michael Wonder on 31 Oct 2021
New and amended PBS listings to help thousands of Australians
30 October 2021 - From 1 November 2021, Australians with a respiratory illness, early onset puberty and blood cancer will have ...
Posted by Michael Wonder on 29 Oct 2021
Public Summary Documents – July 2021 PBAC meeting
29 October 2021 - The public summary documents (positive recommendations and subsequent decisions not to recommend) from the July 2021 PBAC ...
Posted by Michael Wonder on 29 Oct 2021
PBS arrangements for tocilizumab shortage – 1 November 2021
29 October 2021 - In response to the shortages of multiple presentations of tocilizumab (Actemra) products, the PBAC has recommended temporary ...
Posted by Michael Wonder on 28 Oct 2021
Mallinckrodt and Terumo Blood and Cell Technologies announce positive recommendations in Australia for public funding of Uvadex (methoxsalen) for ECP administration with the Therakos Cellex photopheresis system for chronic graft versus host disease in adults
28 October 2021 - In a dual review process, two independent advisory committees to the Australian Minister for Health recommended reimbursement ...